Jane Street’s ABVC BioPharma ABVC Stock Holding History

Jane Street’s Portfolio ABVC Stock Details ABVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,700	Closed	-$10.4K	–	11395
2026 Q1	$10.4K	Buy	+10,700	New	+$17.7K	﹤0.01%	11300

Other funds holding ABVC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street's ABVC Position: Q2 2026 in Review

Jane Street opened a new position in ABVC BioPharma (ABVC) in Q2 2026: 20,059 shares worth $31.7K. The stake represents ﹤0.01% of the portfolio and ranks #11082 among its holdings. This is a return to the name: Jane Street previously reported a position in ABVC as recently as Q4 2025.

Jane Street first reported a position in ABVC in Q3 2022 and has held it in 3 quarters since. 15 funds tracked by Wall St. Rank hold ABVC as of Q2 2026.

Jane Street held 20,059 shares of ABVC BioPharma worth $31.7K as of Q2 2026.
ABVC BioPharma was a new Jane Street position in Q2 2026.
ABVC BioPharma made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11082 holding.
Jane Street first reported a position in ABVC BioPharma in Q3 2022 and has held it in 3 quarters since.
15 funds tracked by Wall St. Rank held ABVC BioPharma as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.